Denmark
  • Europe
    • FR
    • DE
    • IT
    • ES
    • PL
    • BE
    • NL
    • LU
    • CH
    • NO
    • SE
    • FI
    • EE
    • LV
    • LT
  • Denmark
    • Faroe Islands
    • Greenland
    • Copenhagen
  • Business
    • Mærsk
    • Novo Nordisk
    • DSV
    • Ørsted
    • Danske Bank
    • Vestas Wind Systems
    • LEGO
    • DFDS
  • Nordics
    • Stockholm
    • Oslo
    • Helsinki
  • Baltics
    • Tallinn
    • Riga
    • Vilnius
  • Benelux
    • Brussels
    • Amsterdam
  • Warsaw
  • Berlin
  • NATO
  • UK
  • US
  • Africa
  • Amsterdam
  • Berlin
  • Brussels
  • Copenhagen
  • Danske Bank
  • Denmark
  • DFDS
  • DSV
  • Faroe Islands
  • Greenland
  • Helsinki
  • LEGO
  • Mærsk
  • Novo Nordisk
  • Ørsted
  • Oslo
  • Riga
  • Stockholm
  • Tallinn
  • Vestas Wind Systems
  • Vilnius
  • Warsaw
Denmark
  • Europe
    • FR
    • DE
    • IT
    • ES
    • PL
    • BE
    • NL
    • LU
    • CH
    • NO
    • SE
    • FI
    • EE
    • LV
    • LT
  • Denmark
    • Faroe Islands
    • Greenland
    • Copenhagen
  • Business
    • Mærsk
    • Novo Nordisk
    • DSV
    • Ørsted
    • Danske Bank
    • Vestas Wind Systems
    • LEGO
    • DFDS
  • Nordics
    • Stockholm
    • Oslo
    • Helsinki
  • Baltics
    • Tallinn
    • Riga
    • Vilnius
  • Benelux
    • Brussels
    • Amsterdam
  • Warsaw
  • Berlin
  • NATO
  • UK
  • US
  • Africa

Browsing Tag

Pfizer

27 posts
NNovo Nordisk
Award Banner
Read More

Pfizer, Innovent GLP-1 drugs added to China national insurance for diabetes, China News

  • 2026-11-14
SHANGHAI/BEIJING – GLP-1 drugs from Pfizer and Innovent Biologics will be added to China’s state-run health insurance scheme…
NNovo Nordisk
Novartis and Novo Nordisk heart drugs fail despite genetic proof, STAT's Herper says biology "doesn't make sense" — BigGo Finance
Read More

Novartis and Novo Nordisk heart drugs fail despite genetic proof, STAT’s Herper says biology “doesn’t make sense” — BigGo Finance

  • 2026-11-13
Two of the most genetically bulletproof cardiovascular drugs ever put into patients just failed — and they did…
NNovo Nordisk
Employees work production line Novo Nordisk factory
Read More

Blackstone Bets $1.5 Billion on Pfizer Obesity Drug Engineered to Work as a Monthly Alternative to Ozempic

  • 2026-11-13
Employees work on the production line at the Novo Nordisk factory in Hilleroed on September 26, 2023. Novo…
NNovo Nordisk
Eli Lilly's Oral Obesity Drug Wins First Approval in China, Beating Novo — BigGo Finance
Read More

Eli Lilly’s Oral Obesity Drug Wins First Approval in China, Beating Novo — BigGo Finance

  • 2026-11-12
U.S. pharmaceutical giant Eli Lilly on the 12th received China’s first marketing approval for orforglipron, an oral GLP-1…
NNovo Nordisk
Eli Lilly's Oral Weight-Loss Drug Orforglipron Wins Approval in China as Obesity Race Shifts From Needles to Pills — BigGo Finance
Read More

Eli Lilly’s Oral Weight-Loss Drug Orforglipron Wins Approval in China as Obesity Race Shifts From Needles to Pills — BigGo Finance

  • 2026-11-12
China’s weight-loss drug market has officially entered the oral era. China’s National Medical Products Administration announced on Nov.…
NNovo Nordisk
Valeriia Simanovskaia: The GLP-1 Shake-Up Is Not Another Weight-Loss Drug — It's What Happens After the Weight Is Lost — BigGo Finance
Read More

Valeriia Simanovskaia: The GLP-1 Shake-Up Is Not Another Weight-Loss Drug — It’s What Happens After the Weight Is Lost — BigGo Finance

  • 2026-10-16
Eli Lilly sells the same molecule under two names — Mounjaro for diabetes, Zepbound for obesity — and…
NNovo Nordisk
Novo vs. Pfizer: Which Large Drugmaker Offers Better Growth Prospects?
Read More

Novo vs. Pfizer: Which Large Drugmaker Offers Better Growth Prospects?

  • 2026-09-29
Novo NVO and Pfizer PFE are both pharmaceutical giants based in Denmark and the United States, respectively, with…
NNovo Nordisk
Novo Nordisk Files for Approval of Oral Weight-Loss Drug Wegovy in China, Challenging Eli Lilly's Lead — BigGo Finance
Read More

Novo Nordisk Files for Approval of Oral Weight-Loss Drug Wegovy in China, Challenging Eli Lilly’s Lead — BigGo Finance

  • 2026-08-27
Novo Nordisk (NVO.US) announced on the 27th that China’s National Medical Products Administration has accepted its marketing application…
NNovo Nordisk
Pfizer's Obesity Push: Can Berobenatide Take Market Share?
Read More

Pfizer’s Obesity Push: Can Berobenatide Take Market Share?

  • 2026-08-19
The global obesity market is emerging as one of the largest growth opportunities in pharmaceuticals. The market is…
NNovo Nordisk
Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound
Read More

Pfizer’s Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound

  • 2026-08-07
The past few years have been rough on Pfizer (NYSE: PFE). The company has generally posted subpar financial…
NNovo Nordisk
In the Weight-Loss Wars, Novo’s Obesity Pill Is Pulling Way Ahead of Lilly’s
Read More

In the Weight-Loss Wars, Novo’s Obesity Pill Is Pulling Way Ahead of Lilly’s

  • 2026-07-16
The launch of weight-loss pills is the hottest battle in pharma. So far, Eli Lilly LLY 1.15%increase; up…
NNovo Nordisk
Apple App Store
Read More

Is Pfizer on Track to Launch Its Next Lipitor — This Time in the Weight-Loss Market?

  • 2026-07-11
Key Points Pfizer has regrouped in the GLP-1 space and is now working on a long-acting drug option.…
Denmark
www.europesays.com